Tumour characteristics predictive of survival following resection for ductal adenocarcinoma of the head of pancreas

European Journal of Surgical Oncology

Volumn 33, Issue 7, 2007, Pages 892-897

  Garcea, G ^a   Dennison, A R ^a   Ong, S L ^a   Pattenden, C J ^a   Neal, C P ^a   Sutton, C D ^a   Mann, C D ^a   Berry, D P ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

Ductal adenocarcinoma; Pancreatic cancer; Prognosis; Resection; Survival

Indexed keywords

ADULT; ANESTHESIA; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CANCER INVASION; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; INTRAOPERATIVE PERIOD; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PANCREAS RESECTION; PANCREATICODUODENECTOMY; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURGICAL APPROACH; SURVIVAL RATE;

ADULT; CARCINOMA, DUCTAL; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 34548039005     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.02.024     Document Type: Article

References (53)

1. Mancuso A., Calabro F., and Sternberg C.N. Current therapies and advances in the treatment of pancreatic cancer. Crit Rev Oncol Haematol 58 (2006) 213-241
2. Alexakis N., Halloran C., Raraty P., Ghaneh P., Sutton R., and Neoptolemos J.P. Current standards of surgery for pancreatic cancer. Br J Surg 91 (2004) 1410-1427
3. Shimada S., Sakamoto Y., Sano T., and Kosuge T. Prognostic factors after distal pancreatectomy with extended lymphandenopathy for invasive pancreatic adenocarcinoma of the body and tail. Surgery 139 (2006) 288-295
4. Cress R.D., Yin D., Clarke L., Bold R., and Holly E.A. Survival among patients with adenocarcinoma of the pancreas: a population-based study. Cancer Causes Control 17 (2006) 403-409
5. Tseng J.F., Raut P.C., Lee J.E., et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 8 (2004) 935-950
6. Lim J.E., Chien M.W., and Earle C.C. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 237 1 (2003) 74-85
7. Luttges J., Schemm S., Vogel I., Hedderick J., Kremer B., and Kloppel G. The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to immunohistochemical assessment of proliferation. J Pathol 191 (2000) 154-161
8. Benassai G., Mastrorilli M., Quarto G., et al. Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas. J Surg Oncol 73 (2000) 212-218
9. Wagner M., Redaelli C., Lietz M., Seiler C.A., Friess H., and Buchler M.W. Curative resection is the single most important factor determining outcome in patients with pancreatic cancer. Br J Surg 91 (2004) 586-594
10. Moon H.J., An J.Y., Heo J.S., Choi S.J., Joh J.W., and Kim Y.I. Predicting survival after surgical resection for pancreatic ductal adenocarcinoma. Pancreas 32 (2006) 37-43
11. Magistrelli P., Antinori A., Crucitti A., et al. Prognostic factors after surgical resection for pancreatic carcinoma. J Surg Oncol 74 (2000) 36-40
12. Sohn T.A., Yeo C.J., Cameron J.L., et al. Resected adenocarcinoma of the pancreas- 616 patients: results, outcomes and prognostic indicators. J Gastrointest Surg 4 (2000) 567-579
13. Garcea G., Neal C.P., Pattenden C.J., Steward W.P., and Berry D.P. Molecular prognostic markers in pancreatic cancer: a systematic review. Eur J Cancer 41 (2005) 365-379
14. Berger A.C., Watson J.C., Ross E.A., and Hoffman J.P. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surgeon 70 (2004) 235-240
15. Kuhlmann K.F.D., de Castro S.M.M., van Heek T., et al. Microscopically incomplete resection offers acceptable palliation in pancreatic cancer. Surgery 139 (2006) 188-196
16. Kuhlmann K.F.D., de Castro S.M.M., Wesseling J.G., et al. Surgical treatment of pancreatic adenocarcinoma: actual survival and prognostic factors in 343 patients. Eur J Cancer 40 (2004) 549-558
17. Shoup M., Conlon K.C., Klimstra D., and Brennan M.F. Is extended resection for adenocarcinoma of the body or tail of the pancreas justified. J Gastrointest Surg 7 (2003) 946-952
18. Ahmad N.A., Lewis J.D., Ginsberg G.G., et al. Long term survival after pancreatic resection for pancreatic adenocarcinoma. Am J Gastroenterol 96 (2001) 2609-2615
19. van Geenan R.C.I., van Gulik T.M., Offerhaus G.J.A., et al. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update. Eur J Surg Oncol 27 (2001) 549-557
20. Bouvet M., Gamagami R.A., Gilpin E.A., et al. Factors influencing survival after resection for periampullary neoplasma. Am J Surg 180 (2000) 13-17
21. Allison D.C., Piantadosi S., Hruban R.H., et al. DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma. J Surg Oncol 67 (1998) 151-159
22. Delcore R., Rodriguez F.J., Forster J., Hermreck A.S., and Thomas J.H. Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resection. Am J Surg 172 (1996) 463-469
23. Nakaghori T., Kinoshita T., Konishi M., Takahashi S., and Gotohda N. Nodal involvement is the strongest predictor of poor survival in patients with invasive adenocarcinoma of the head of the pancreas. Hepatogastroenterology 53 (2006) 447-451
24. Yeo C.J., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 221 6 (1995) 721-731 [discussion 731-3]
25. Wenger F.A., Peter F., Zieren J., Steiert A., Jacobi C.A., and Muller J.M. Prognosis factors in carcinoma of the head of the pancreas. Dig Surg 17 (2000) 29-35
26. Allema J.H., Reinders M.E., van Gulik T.M., et al. Portal vein resection in patients undergoing pancreaticoduodenectomy for carcinoma in the pancreatic head. Br J Surg 81 (1994) 1642-1646
27. Allema J.H., Reinders M.E., van Gulik T.M., et al. Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer 75 8 (1995) 2069-2076
28. Zhou G.W., Wu W.D., Xiao W.D., Li H.W., and Peng C.H. Pancreatectomy combined with superior mesenteric-portal vein resection: report of 32 cases. Hepatobil Pancreatic Dis Int 4 (2005) 130-134
29. Jarufe N.P., Coldham C., Mayer A.D., Mirza D.F., Buckels J.A., and Bramhall S.R. Favourable prognostic factors in a large UK experience of adenocarcinoma of the head of the pancreas and periampullary region. Dig Surg 21 3 (2004) 202-209
30. Yeo C.J., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphandenectomy for periampullary adenocarcinoma. Part 2: Randomized controlled trial evaluating survival, morbidity and mortality. Ann Surg 236 (2002) 355-366
31. Yeo C.J., Cameron J.L., Sohn T.A., et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphandenectomy for periampullary carcinoma, comparison of morbidity and mortality and short-term outcome. Ann Surg 229 (1996) 613-624
32. Mukaiya M., Hirata K., Satoh T., et al. Lack of survival benefit of extended lymph node dissection for ductal adenocarcinoma of the head of the pancreas: retrospective multi-institutional analysis in Japan. World J Surg 22 (1998) 248-253
33. Henne-Bruns D., Vogel I., Luttges J., Kloppel G., and Kremer B. Surgery for ductal adenocarcinoma of the pancreatic head. Staging, complications, and survival after regional versus extended lymphandenectomy. World J Surg 24 (2000) 595-601
34. Leach S.D., Lee J.E., Charnsangavei C., et al. Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluent adenocarcinoma of the pancreatic head. Br J Surg 85 (1998) 611-617
35. Bachellier P., Nakano H., Oussoultzoglou E., et al. Is pancreaticoduodenectomy with mesenteric portal venous resection safe and worthwhile?. Am J Surg 182 (2001) 120-129
36. Nakaghori T., Kinoshita T., Konishi M., Inoue K., and Takahashi S. Survival benefits of portal vein resection for pancreatic cancer. Am J Surg 186 (2003) 149-153
37. Sasson A., Hoffman J.P., Ross E.A., Kagan S.A., Pingpank J.F., and Eisenberg B.L. En Bloc resection for locally advanced cancer of the pancreas: Is it worthwhile?. J Gastrointest Surg 6 (2002) 147-158
38. Neoptolemos J.P., Stocken D.D., Dunn J.A., Almond J., Beger H., and Perderzoli P. Influence of resection margins on survival fro patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 234 (2001) 758-768
39. Lillemoe K.D., Cameron J.L., Yeo C.J., Sohn T.A., Nakeeb A., and Sauter P.K. Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer. Ann Surg 223 (1996) 718-725
40. Matsuno S., and Sato T. Surgical treatment of carcinoma of the pancreas. Experience in 272 patients. Am J Surg 152 (1986) 499-504
41. Greer R.J., and Brennan M.F. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 165 (1993) 68-73
42. Nitecki S.S., Sarr M.G., Colby T.V., and van Heerden J.A. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?. Ann Surg 221 1 (1995) 59-66
43. Sperti C., Pasquali C., Piccoli A., and Pedrazzoli S. Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg 83 5 (1996) 625-631
44. Hirata K., Sato T., Mukaiya M., et al. Results of 1001 pancreatic resections for invasive ductal adenocarcinoma of the pancreas. Arch Surg 132 (1997) 771-776
45. Connor S., Bosonnet L., Ghaneh P., et al. Survival of patients with periampullary carcinoma is predicted by lymph node 8a but not by lymph node 16b1 status. Br J Surg 91 (2004) 1592-1599
46. Cameron J.L., Riall T.S., Coleman J., and Belcher K.A. One thousand consecutive pancreaticoduodenectomies. Ann Surg 244 (2006) 10-15
47. Cameron J.L., Crist D.W., Sitzmann J.V., et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 161 1 (1991) 120-124 [discussion 124-5]
48. Trede M., Schwall G., and Saeger H.D. Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 211 (1990) 447-458
49. Connolly M.M., Dawson P.J., and Michelassi F. Survival in 1001 patients with carcinoma of the pancreas. Ann Surg 206 (1987) 366-371
50. Sellner A.J., Riegler F.M., and Machacek E. Implication of histological grade of tumour for the prognosis of radically resected periampullary carcinoma. Eur J Surg 165 (1999) 865-870
51. Shimada K., Sakamoto Y., Sano T., Kosuge T., and Hiraoka N. Reappraisal of the clinical significance of tumour size in patients with pancreatic ductal adenocarcinoma. Pancreas 33 (2006) 233-239
52. Sierzega M., Popiela T., Kulig J., and Nowak K. The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic cancer. Pancreas 33 (2006) 240-245
53. Schwarz R.E., and Smith D.D. Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database. Ann Surg Oncol 13 (2006) 1189-11200